SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCER
- 1 March 1982
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 319 (8272) , 583-585
- https://doi.org/10.1016/s0140-6736(82)91748-2
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Plasma Calcitonin as a Marker of Disease Activity in Patients with Small Cell Carcinoma of the Lung*Journal of Clinical Endocrinology & Metabolism, 1981
- Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung.Proceedings of the National Academy of Sciences, 1981
- NEURON-SPECIFIC ENOLASE IS PRODUCED BY NEUROENDOCRINE TUMOURSThe Lancet, 1981
- A More Sensitive Radioimmunoassay for Neuron‐Specific Enolase Suitable for Cerebrospinal Fluid DeterminationsJournal of Neurochemistry, 1981
- ACTH, ADH, and calcitonin concentrations as markers of response and relapse in small-cell carcinoma of the lungCancer, 1980
- Diagnostic and therapeutic implications of ectopic hormone production in small cell carcinoma of the lungThorax, 1980
- Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancerJAMA, 1979
- Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cellsNature, 1978
- Variable Content of Histaminase, L-Dopa Decarboxylase and Calcitonin in Small-Cell Carcinoma of the LungNew England Journal of Medicine, 1978
- Neuronal, non-neuronal and hybrid forms of enolase in brain: Structural, immunological and functional comparisonsBrain Research, 1978